Skip header and navigation

Refine By

10937 records – page 1 of 1094.

Role expectancies, race, and treatment outcome in rural mental health

https://arctichealth.org/en/permalink/ahliterature265510
Source
American Journal of Psychotherapy. 2014;68(3):339-354
Publication Type
Article
Date
2014
Author
Aubuchon-Endsley, NL
Callahan, JL
Scott, S
Source
American Journal of Psychotherapy. 2014;68(3):339-354
Date
2014
Language
English
Publication Type
Article
Keywords
Expectancies
Native American
Psychotherapy
Race
Treatment Outcome
Abstract
This study is the first report examining the relationship between pretreatment expectancy and treatment outcome in Osage Native Americans receiving mental health services. Results reveal that in Native American participants, high expectations for advice and approval in therapy may lead to poor treatment outcomes. Conversely, low expectancies may be risk factors for poor outcomes among White American individuals. Therefore, practitioners should consider client race during assessment and appropriately address problematic pretreatment expectancies to prevent poor treatment outcome. Given the differences in direction of effects between races, it may be best to increase advice and approval of therapeutic roles when working with Native American clients; whereas, it may be best to increase pretreatment expectancies with White American clients. Results are particularly notable given that Native American clients are pervasively under-researched and under-served.
Less detail

Re: "Waiting for radiotherapy in Ontario" by Mackillop et al. and "in response to 'waiting..."' by L.W. Brady, IJROBP 30; 1994.

https://arctichealth.org/en/permalink/ahliterature214931
Source
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):895-6
Publication Type
Article
Date
Jun-15-1995
Author
E W Gerner
Source
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):895-6
Date
Jun-15-1995
Language
English
Publication Type
Article
Keywords
Humans
Neoplasms - radiotherapy
Ontario
Time Factors
Treatment Outcome
Notes
Comment On: Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):245-68083124
Comment On: Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):221-88083117
PubMed ID
7790280 View in PubMed
Less detail

[The choice and substantiation of optimal strategies in the surgical treatment of thyroid cancer]

https://arctichealth.org/en/permalink/ahliterature20188
Source
Klin Khir. 2000 Aug;(8):50-3
Publication Type
Article
Date
Aug-2000

[The implementation of the method of enhanced external counter pulsation for the treatment of cardiovascular diseases].

https://arctichealth.org/en/permalink/ahliterature300503
Source
Vopr Kurortol Fizioter Lech Fiz Kult. 2018 May 21; 95(2):51-57
Publication Type
Journal Article
Review
Date
May-21-2018
Author
V A Badtieva
D N Voroshilova
Author Affiliation
Moscow Research and Practical Centre for Medical Rehabilitation, Restorative and Sports Medicine, Moscow Health Department.
Source
Vopr Kurortol Fizioter Lech Fiz Kult. 2018 May 21; 95(2):51-57
Date
May-21-2018
Language
Russian
Publication Type
Journal Article
Review
Keywords
Cardiovascular Diseases - therapy
Counterpulsation - methods
Humans
Russia
Treatment Outcome
Abstract
The cardiovascular diseases occupy a leading place in the structure of overall morbidity affecting the population not only of Russia but also of the majority of the developed countries throughout the world; they thus impose the heavy social and economic burden on both the public healthcare services and the modern society in general. At the same time, systemic atherosclerosis is considered to be one of the most common, severe, and life-threatening condition. Despite the presence of a large number of pharmaceutical and surgical methods for the treatment of this pathology, they are not infrequently lacking the desired effectiveness. The use of the shunting operations and endovascular methods failed to radically resolve the problem of managing systemic atherosclerosis and atherosclerosis of the lower limbs. A relatively novel approach which currently begins to find the ever increasing application for the treatment of patients presenting with cardiovascular pathology is based on the enhanced external counter-pulsation method although both the clinical and theoretical prerequisites of its application were developed rather long ago. This non-invasive therapeutic method allows to increase the perfusion pressure in the coronary arteries in diastole and to reduce the resistance to the cardiac ejection in the systole. The objective of this review article was to perform the analysis of the available literature publications on the use of the enhanced external counter-pulsation technique for the treatment of the patients presenting with the diseases of the cardiovascular system and to evaluate the clinical effectiveness of this approach as well as the availability of the treatment for the patients.
????????-?????????? ????????? ???????? ??????? ????? ? ????????? ?????????????? ????????? ?? ?????? ? ??????, ?? ? ? ?????? ???????? ??????? ????, ?????? ???????????? ?????????? ? ????????????? ????? ???????????? ????????. ??? ???? ????????? ???????????? ??????????????? ??? ???? ?? ???????? ????????????????, ????????? ? ?????????? ????? ???????????. ???????? ?? ??????? ???????? ?????????? ??????????????? ? ????????????? ???????? ??????? ?????? ?????????, ??? ?? ?????? ??????????. ?????????? ??????????? ???????? ? ??????????????? ??????? ?? ?????? ???????? ??????? ?????????? ????????????? ? ????????????? ?????? ???????????. ???????????? ????? ???????, ??????? ??? ????? ??????? ??????????? ??? ??????? ????????? ? ?????????? ??????????, ???????? ?? ?????????? ????? ???????????? ????????????? ? ????????????????? ??????????? ??? ?????????????, ???????? ????????? ???????? ??????????????. ??? ???????????? ????? ???????, ??????????? ???????? ?????????? ????????????? ???????? ? ?????????? ???????? ? ???????? ? ???????? ????????????? ?????????? ??????? ? ???????. ???? ?????? — ???????? ?????? ?????? ?????????? ?? ????????????? ????????? ???????? ?????????????? ? ??????? ??????????? ????????-?????????? ??????? ? ??????? ????????????? ?????????? ??????? ?????? ? ??????????? ??? ?????????.
PubMed ID
29786682 View in PubMed
Less detail

[Fertilization in vitro--success rate and registration. A clarification]

https://arctichealth.org/en/permalink/ahliterature64809
Source
Tidsskr Nor Laegeforen. 1993 Jun 10;113(15):1883
Publication Type
Article
Date
Jun-10-1993
Author
K W Ruyter
F. Forsdahl
Source
Tidsskr Nor Laegeforen. 1993 Jun 10;113(15):1883
Date
Jun-10-1993
Language
Norwegian
Publication Type
Article
Keywords
Female
Fertilization in Vitro
Humans
Norway
Pregnancy
Registries
Treatment Outcome
PubMed ID
8322333 View in PubMed
Less detail

[Traditional medicine treatment in 1860].

https://arctichealth.org/en/permalink/ahliterature151749
Source
Tidsskr Nor Laegeforen. 2009 Mar 26;129(7):644-5
Publication Type
Article
Date
Mar-26-2009
Author
Erik Ingebrigtsen
Author Affiliation
Institutt for historie og klassiske fag Norges teknisk-naturvitenskapelige universitet 7491 Trondheim. erik.ingebrigtsen@hf.ntnu.no
Source
Tidsskr Nor Laegeforen. 2009 Mar 26;129(7):644-5
Date
Mar-26-2009
Language
Norwegian
Publication Type
Article
Keywords
History, 19th Century
Humans
Medicine, Traditional - history
Norway
Treatment Outcome
PubMed ID
19337337 View in PubMed
Less detail

A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients.

https://arctichealth.org/en/permalink/ahliterature79821
Source
Vox Sang. 2006 Nov;91(4):316-23
Publication Type
Article
Date
Nov-2006
Author
Edgren G.
Hjalgrim H.
Tran T N
Rostgaard K.
Shanwell A.
Titlestad K.
Jakobsson L.
Gridley G.
Wideroff L.
Jersild C.
Adami J.
Melbye M.
Reilly M.
Nyrén O.
Author Affiliation
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Source
Vox Sang. 2006 Nov;91(4):316-23
Date
Nov-2006
Language
English
Publication Type
Article
Keywords
Blood Donors
Disease Transmission
Humans
International Cooperation
Registries
Treatment Outcome
Abstract
BACKGROUND AND OBJECTIVES: Even with appropriate donor deferrals and advanced screening tests, the risk of disease transmission through blood transfusion cannot be completely disregarded. Efficient monitoring of possible disease transmission between blood donors and recipients should be an important component of a comprehensive haemovigilance system. MATERIALS AND METHODS: We assembled the Scandinavian Donations and Transfusions (SCANDAT) database, with data on virtually all blood donors and recipients who have been registered at least once in any of the computerized local blood bank databases in Sweden and Denmark since the start of computerized registration in 1966. The records of these individuals, with their entire computerized donation and/or transfusion histories and all donor-component-recipient connections, were linked to nationwide population and health registers to attain essentially complete follow-up for up to 36 years regarding reproduction, hospital morbidity, cancer, and death. RESULTS: After data cleaning, the database contained 1,134,290 blood donors who contributed 15,091,280 records of donations and 1,311,079 recipients who received 11,693,844 transfusions. The data quality in the existing data sources was satisfactory. From the data obtained from local blood banks, 4.6%, 1.6%, and 6.4% of the person, donation, and transfusion records, respectively, had to be discarded after review of the legitimacy of recorded values, and comparisons with independent, external databases. CONCLUSION: It is possible to use existing computerized data, collected in routine health care, in haemovigilance systems for monitoring long-term outcome and disease concordance in blood donors and transfusion recipients.
PubMed ID
17105607 View in PubMed
Less detail

Survey of the management of pancreatic pseudocysts in Sweden.

https://arctichealth.org/en/permalink/ahliterature98952
Source
Scand J Gastroenterol. 2009;44(10):1252-8
Publication Type
Article
Date
2009
Author
Bodil Andersson
Ake Andrén-Sandberg
Roland Andersson
Author Affiliation
Department of Surgery, Lund University Hospital, Lund, Sweden. bodil.andersson@med.lu.se
Source
Scand J Gastroenterol. 2009;44(10):1252-8
Date
2009
Language
English
Publication Type
Article
Keywords
Female
Humans
Male
Pancreatic Pseudocyst - therapy
Questionnaires
Sweden
Treatment Outcome
Abstract
OBJECTIVE: The management of pancreatic pseudocysts varies, based mainly on local traditions, resources and expertise. No prospective, randomized study has been done comparing different approaches to treatment. The aim of the present study was to identify current treatment strategies in Sweden. MATERIAL AND METHODS: A questionnaire comprising 12 questions was e-mailed to the surgical departments of all hospitals (n=58) treating patients with pancreatitis. Comparisons were made between university and non-university hospitals and between hospitals with 150,000 or more persons versus less in the primary catchment area. RESULTS: Fifty-one hospitals responded (88%). In median, 4 (0-25) patients were treated yearly due to pancreatic pseudocysts at each hospital. Five hospitals had written guidelines. Multidisciplinary team conferences were held at 36/48 centres. Treatment strategies for acute compared to chronic pancreatitis associated pseudocysts differed significantly depending on the underlying diagnosis in the major hospitals (p=0.005). Overall, 21/49 hospitals refer some of these patients and 15/50 of the departments state that they regularly assist in taking care of patients with pancreatic pseudocysts from other hospitals. The chosen treatment modalities vary widely, above all concerning endoscopic drainage, which is more common for symptomatic non-infected pseudocysts (p=0.005) as well as infected pseudocysts (p=0.004) in university hospitals. CONCLUSIONS: The lack of protocols and management strategies for pancreatic pseudocysts is reflected by the heterogeneity in treatment strategies, as seen in the present survey. Therefore patients may be at risk of receiving suboptimal treatment. A tailored therapeutic approach that takes into consideration patient preferences and involves a multidisciplinary team should be considered in all cases.
PubMed ID
19658018 View in PubMed
Less detail

DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial.

https://arctichealth.org/en/permalink/ahliterature104880
Source
Am Heart J. 2014 Mar;167(3):322-8
Publication Type
Article
Date
Mar-2014
Author
Robin Hofmann
Stefan K James
Leif Svensson
Nils Witt
Mats Frick
Bertil Lindahl
Ollie Östlund
Ulf Ekelund
David Erlinge
Johan Herlitz
Tomas Jernberg
Author Affiliation
Karolinska Institutet, Department of Clinical Science and Education, Division of Cardiology, Södersjukhuset, Stockholm, Sweden. Electronic address: robin.hofmann@ki.se.
Source
Am Heart J. 2014 Mar;167(3):322-8
Date
Mar-2014
Language
English
Publication Type
Article
Keywords
Humans
Myocardial Infarction - therapy
Oxygen Inhalation Therapy
Registries
Sweden
Treatment Outcome
Abstract
The use of supplemental oxygen in the setting of suspected acute myocardial infarction (AMI) is recommended in international treatment guidelines and established in prehospital and hospital clinical routine throughout the world. However, to date there is no conclusive evidence from adequately designed and powered trials supporting this practice. Existing data are conflicting and fail to clarify the role of supplemental oxygen in AMI.
A total of 6,600 normoxemic (oxygen saturation [SpO2] =90%) patients with suspected AMI will be randomly assigned to either supplemental oxygen 6 L/min delivered by Oxymask (MedCore Sweden AB, Kista, Sweden) for 6 to 12 hours in the treatment group or room air in the control group. Patient inclusion and randomization will take place at first medical contact, either before hospital admission or at the emergency department. The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies registry will be used for online randomization, allowing inclusion of a broad population of all-comers. Follow-up will be carried out in nationwide health registries and Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies. The primary objective is to evaluate whether oxygen reduces 1-year all-cause mortality. Secondary end points include 30-day mortality, major adverse cardiac events, and health economy. Prespecified subgroups include patients with confirmed AMI and certain risk groups. In a 3-month pilot study, the study concept was found to be safe and feasible.
The need to clarify the uncertainty of the role of supplemental oxygen therapy in the setting of suspected AMI is urgent. The DETO2X-AMI trial is designed and powered to address this important issue and may have a direct impact on future recommendations.
PubMed ID
24576515 View in PubMed
Less detail

[Is quality assurance of registration and publishing of therapeutic results sufficient?].

https://arctichealth.org/en/permalink/ahliterature200479
Source
Tidsskr Nor Laegeforen. 1999 Sep 20;119(22):3342
Publication Type
Article
Date
Sep-20-1999
Author
J J Jørgensen
Source
Tidsskr Nor Laegeforen. 1999 Sep 20;119(22):3342
Date
Sep-20-1999
Language
Norwegian
Publication Type
Article
Keywords
Humans
Norway
Publishing
Quality Assurance, Health Care
Registries - standards
Treatment Outcome
PubMed ID
10533423 View in PubMed
Less detail

10937 records – page 1 of 1094.